Interactive booklet reduces antibiotic prescribing for respiratory tract infections in children, but not parent satisfaction
The reason this randomised controlled trial is important is because it addresses a common challenge for primary healthcare services internationally. The intervention aims to promote appropriate parental demand for consultations and antibiotics for children with respiratory tract infections (RTIs). This is important for parents, clinicians and policy for three reasons. First, RTIs are extremely common and are costly to service providers, families, schools and parents' employers. 1 Second, there is considerable clinical uncertainty in primary care regarding the diagnosis and best management of RTIs. This is refl ected by the variation in the use of antibiotics in primary care for RTIs among nations, 2 GP practices 3 and clinicians. 4 UK clinicians have reduced antibiotic prescribing by around 30% in children in the past 10 years, 5 but further reductions of up to 30% are possible given the experience of other northern European countries. 2 Finally, the overuse of antibiotics is associated with the development of antimicrobial resistance and increased health-seeking behaviour. 6 It has been shown that increasing (or decreasing) the use of antibiotics can lead to vicious (or virtuous) reconsultation cycles.
What was new about this intervention is that the use of the booklet was brought into the clinical consultation. Previous studies have assessed the effects of posting written information to patients when they were well (largely ineffective) [7] [8] [9] or when they were unwell but for them to read after the consultation. This latter approach was shown to be effective in reducing reconsultations 10 and antibiotic prescribing. 11 To prevent contamination of the use of the booklet between intervention and control among clinicians, the investigators clustered randomised GP practices to receive online training in the use of a booklet or usual care. The training encouraged the clin icians to explore parents' concerns, ask about their expectations, discuss prognosis (eg, symptom duration), discuss treatment options and consider when parents should reconsult. The investigators hypothesised that the intervention would reduce reconsultations in the 2 weeks after recruitment from 20% to 10%. Secondary outcomes included antibiotic prescribing, antibiotic consumption, satisfaction, enablement and reassurance. The trial could not detect an effect on reconsultation behaviour (reduced from 16% to 13%; odds ratio 0.75. 95%CI 0.41 to 1.38) but did fi nd a clinically important reduction in immediate or delayed antibiotic prescribing (from 41% to 20%; odds ratio 0.29, 95% CI 0.14 to 0.60), antibiotic consumption and parental intention to consult for similar future illnesses. No differences were detected in the remaining outcomes. The authors conclude that the online training and booklet reduced antibiotic prescribing and future consultation intention without reducing satisfaction with care.
This was a well-conducted and well-reported trial with no evidence of post-randomisation selection bias, an important limitation of some cluster trials. It appears to have been adequately powered for the (secondary) antibiotic prescribing outcome, but may not have been sufficiently powered for the (primary) reconsultation outcome. The authors suggest that poor intervention fi delity could be responsible for the reconsultation outcome but given the pragmatic nature of the trial, these are the sorts of results that we might expect to see in a real-world health service context. In my view, the authors are also correct in considering that the observed antibiotic prescribing effect might be mediated by an interaction between the booklet and clinician (desirable) and/or an increased sense of study-related scrutiny (the Hawthorne effect), although I suspect more the former.
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So, is this booklet ready for application in clinical practice? For individual clinicians I would say yes, because its use is associated with benefi t without apparent harm (although outcomes such as hospitalisation are too infrequent to be conclusive in studies of this size). However, recommending its use at a population level requires a little more evidence, namely, cost-effectiveness, longer-term (>2 weeks) outcomes and safety (eg, outcomes such as symptom duration and hospitalisation). I understand from the lead author that both a cost-effectiveness analy sis and a longer-term consultation rate analysis have been conducted. We await these results with interest.
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